Physician profile
Marc Plawker
NPI 1588642250
$2,990.19
in general payments reported to CMS, 2019-2025
33 companies · $674 in 2025
The $674 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $390 · 2021: $473 · 2022: $468 · 2023: $333 · 2024: $283 · 2025: $674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $485.76 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $418.95 | 2019-2024 | Myrbetriq, Xtandi |
| Tolmar, INC. | $253.10 | 2024-2025 | Eligard |
| Urovant Sciences INC | $156.66 | 2021-2022 | |
| 180 Medical, INC. | $155.66 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $147.80 | 2019-2025 | |
| Amgen INC. | $125.29 | 2020-2023 | Xgeva |
| Abbvie INC. | $124.11 | 2020-2024 | |
| Boston Scientific Corporation | $123.28 | 2019-2025 | Spaceoar System, Spaceoar Vue System - 10ml |
| Ferring Pharmaceuticals INC. | $100.19 | 2024-2025 | Adstiladrin |
| Progenics Pharmaceuticals, INC. | $92.64 | 2021-2025 | Pylarify |
| Endo Pharmaceuticals INC. | $86.74 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $85.20 | 2023-2025 | Orgovyx, Gemtesa |
| Olympus America INC. | $63.24 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $59.95 | 2020-2023 | Lynparza, Keytruda |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $54.58 | 2025 | Aveed, Xiaflex |
| Verity Pharmaceuticals INC. | $50.38 | 2023-2024 | Trelstar |
| Myovant Sciences INC. | $46.79 | 2022 | |
| Immunitybio, INC. | $45.26 | 2025 | |
| Allergan, INC. | $38.06 | 2019-2021 | |
| Teleflex LLC | $35.43 | 2021-2023 | Urolift |
| Dentsply Ih INC. | $31.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $28.19 | 2021-2023 | |
| Dendreon Pharmaceuticals LLC | $26.87 | 2021 | |
| Hollister Incorporated | $24.59 | 2023 | Infyna Chic, Vapro Pocket |
| Palette Life Sciences, INC. | $20.77 | 2022 | |
| Inspire Medical Systems, INC. | $19.00 | 2025 | Inspire |
| Antares Pharma, INC. | $17.82 | 2022 | |
| Procept Biorobotics Corporation | $16.03 | 2023 | Aquabeam Robotic System |
| Laborie Medical Technologies Corp. | $15.71 | 2020 | |
| Bioprotect Medical, INC. | $14.35 | 2024 | Bioprotect Balloon Implant System |
| Mission Pharmacal Company | $14.21 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Plawker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.